What is Euro-Med Laboratories Philippines FCF Margin %?
Euro-Med Laboratories PhilippinesPHS:EURO 83 FCF Margin % is 18.56% as of Mar. 2026, which is 1275% above its 10-year median of 1.35. GuruFocus rates PHS:EURO with a GF Score™ of 83/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 6 warning signs investors should review. Among 958 Drug Manufacturers companies, Euro-Med Laboratories Philippines ranks better than 75.47% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHS:EURO vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines (PHS:EURO) has a FCF Margin % of 18.56% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 1275% above median its historical median of 1.35. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #235 out of 958 companies in the Drug Manufacturers industry, placing it in the top 24.5%.
Is Euro-Med Laboratories Philippines' FCF Margin % too high?
Euro-Med Laboratories Philippines' current FCF Margin % of 18.56% is 1275% above median its 10-year median of 1.35. The Drug Manufacturers industry median FCF Margin % is 2.45. Euro-Med Laboratories Philippines' value of 18.56% is 659.1% above this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #235 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #235 out of 958 companies for FCF Margin %. This places Euro-Med Laboratories Philippines in the top 25% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.45. Euro-Med Laboratories Philippines' value of 18.56% is 659.1% above this benchmark. While the company's 10-year median is 1.35 vs. the industry median of 2.45, Euro-Med Laboratories Philippines has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current FCF Margin % of 18.56% is 659.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current FCF Margin % is 18.56%, which is 1275% above median its own 10-year median of 1.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.08 — trading 5.9% above its estimated fair value. The current FCF Margin % is 18.56%, which is 1275% above median its 10-year median of 1.35 and 659.1% above the Drug Manufacturers industry median of 2.45. Euro-Med Laboratories Philippines' overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current FCF Margin % is 18.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.08 is trading 5.9% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
FCF Margin %: 18.56% (1275% above median its 10-year median of 1.35)
GF Value™: ₱1.02 vs. price of ₱1.08 (5.9% above fair value)
Industry Position: 659.1% above the Drug Manufacturers median (#235 of 958)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
83GF Score
Get the complete analysis for PHS:EURO
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
